We are live on ! Find out more
6CM

683 Capital Management Portfolio holdings

AUM $1.92B
1-Year Est. Return 85.52%
This Fund
S&P 500
This Quarter Est. Return
-26.82%
1 Year Est. Return
+85.52%
3 Year Est. Return
+282.16%
5 Year Est. Return
+254.87%
10 Year Est. Return
+3,288.81%
AUM
$1.65B
AUM Growth
+$109M
Cap. Flow
+$339M
Cap. Flow %
20.52%
Top 10 Hldgs %
53.93%
Holding
215
New
51
Increased
41
Reduced
14
Closed
25

Sector Composition

Rank Sector Weight
1 Healthcare 13.2%
2 Communication Services 8.08%
3 Consumer Discretionary 5.56%
4 Financials 3.95%
5 Materials 1.76%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
FENC icon
51
Fennec Pharmaceuticals
FENC
$344M
$6.2M 0.38%
971,351
SNDX icon
52
Syndax Pharmaceuticals
SNDX
$1.73B
$5.98M 0.36%
1,342,839
+821,839
+158% +$4.51M
HCC icon
53
Warrior Met Coal
HCC
$4.25B
$5.91M 0.36%
+245,000
New +$6.26M
NMCI
54
DELISTED
Navios Maritime Containers L.P. Common Units
NMCI
$5.55M 0.34%
+1,962,199
New +$6.15M
FATE icon
55
Fate Therapeutics
FATE
$293M
$5.2M 0.31%
405,000
-244,800
-38% -$3.41M
VRDN icon
56
Viridian Therapeutics
VRDN
$2.2B
$5.14M 0.31%
+113,136
New +$6.54M
BX icon
57
Blackstone
BX
$102B
$5.07M 0.31%
170,000
MO icon
58
PUT
Altria Group
MO
$113B
$4.94M 0.3%
100,000
MGNX icon
59
MacroGenics
MGNX
$240M
$4.89M 0.3%
384,970
+49,336
+15% +$827K
ELVT
60
DELISTED
Elevate Credit, Inc.
ELVT
$4.68M 0.28%
+1,045,305
New +$5.48M
KRE icon
61
PUT
State Street SPDR S&P Regional Banking ETF
KRE
$4.49B
$4.68M 0.28%
100,000
+50,000
+100% +$2.67M
ORCL icon
62
PUT
Oracle
ORCL
$367B
$4.51M 0.27%
100,000
-100,000
-50% -$4.79M
EXPE icon
63
PUT
Expedia Group
EXPE
$35.2B
$4.51M 0.27%
+40,000
New +$4.79M
AMR icon
64
Alpha Metallurgical Resources
AMR
$1.82B
$4.38M 0.27%
+66,625
New +$4.46M
DESP
65
DELISTED
Despegar.com
DESP
$4.34M 0.26%
+350,000
New +$5.28M
T icon
66
PUT
AT&T
T
$159B
$4.28M 0.26%
+198,600
New +$4.62M
XRT icon
67
CALL
State Street SPDR S&P Retail ETF
XRT
$453M
$4.1M 0.25%
+100,000
New +$4.57M
MDLZ icon
68
PUT
Mondelez International
MDLZ
$80.5B
$4M 0.24%
100,000
MRNS
69
DELISTED
Marinus Pharmaceuticals, Inc
MRNS
$3.88M 0.23%
337,500
+62,500
+23% +$1.26M
INSE icon
70
Inspired Entertainment
INSE
$182M
$3.85M 0.23%
801,824
+43,394
+6% +$270K
SBBP
71
DELISTED
Strongbridge Biopharma plc.
SBBP
$3.8M 0.23%
848,700
+549,000
+183% +$2.68M
CFRX
72
DELISTED
ContraFect Corporation
CFRX
$3.49M 0.21%
2,850
NOV icon
73
NOV
NOV
$6.93B
$3.34M 0.2%
130,000
-165,000
-56% -$5.7M
MDCO
74
DELISTED
Medicines Co
MDCO
$3.2M 0.19%
167,252
FBRX icon
75
Forte Biosciences
FBRX
$1.58B
$3.08M 0.19%
1,000
+867
+652% +$3.73M

Similar funds

683 Capital Management's Q4 2018 Portfolio in Review

As of Q4 2018, 683 Capital Management held 215 positions worth $1.65B, up 7.1% from $1.54B the previous quarter. Its ten largest holdings account for 54% of the portfolio.

683 Capital Management deployed $339M of net new capital in Q4 2018, opening 51 new positions and adding to 41 existing holdings. Its largest new stake was Capital One: 246,000 shares worth $18.6M.

By sector, the portfolio is most concentrated in Healthcare at 13% of assets, down from 15% a quarter earlier, followed by Communication Services and Consumer Discretionary.

On the sell side, the largest reduction was Kroger, an estimated $7.83M trimmed.

  • 683 Capital Management's largest Q4 2018 buy was Capital One: 246,000 shares worth $18.6M.
  • 683 Capital Management added most to Scorpio Tankers in Q4 2018, an estimated $18M increase.
  • 683 Capital Management's biggest Q4 2018 reduction was Kroger, cutting an estimated $7.83M.
  • 683 Capital Management fully exited New York REIT, Inc. in Q4 2018, selling an estimated $15.5M.
  • 683 Capital Management's ten largest holdings make up 54% of its $1.65B portfolio in Q4 2018.
  • 683 Capital Management opened 51 new positions and closed 25 in Q4 2018.
  • 683 Capital Management's portfolio value rose 7.1% quarter-over-quarter to $1.65B.

Based on 683 Capital Management's 13F filing for Q4 2018, filed 14 Feb 2019.